Suppr超能文献

利用蛋白质稳定性计算构建苯丙酮尿症基因型-表型相关性的机制模型。

Toward mechanistic models for genotype-phenotype correlations in phenylketonuria using protein stability calculations.

机构信息

The Linderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen, Denmark.

Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark.

出版信息

Hum Mutat. 2019 Apr;40(4):444-457. doi: 10.1002/humu.23707. Epub 2019 Jan 25.

Abstract

Phenylketonuria (PKU) is a genetic disorder caused by variants in the gene encoding phenylalanine hydroxylase (PAH), resulting in accumulation of phenylalanine to neurotoxic levels. Here, we analyzed the cellular stability, localization, and interaction with wild-type PAH of 20 selected PKU-linked PAH protein missense variants. Several were present at reduced levels in human cells, and the levels increased in the presence of a proteasome inhibitor, indicating that proteins are proteasome targets. We found that all the tested PAH variants retained their ability to associate with wild-type PAH, and none formed aggregates, suggesting that they are only mildly destabilized in structure. In all cases, PAH variants were stabilized by the cofactor tetrahydrobiopterin (BH ), a molecule known to alleviate symptoms in certain PKU patients. Biophysical calculations on all possible single-site missense variants using the full-length structure of PAH revealed a strong correlation between the predicted protein stability and the observed stability in cells. This observation rationalizes previously observed correlations between predicted loss of protein destabilization and disease severity, a correlation that we also observed using new calculations. We thus propose that many disease-linked PAH variants are structurally destabilized, which in turn leads to proteasomal degradation and insufficient amounts of cellular PAH protein.

摘要

苯丙酮尿症(PKU)是一种由编码苯丙氨酸羟化酶(PAH)的基因变异引起的遗传疾病,导致苯丙氨酸积累到神经毒性水平。在这里,我们分析了 20 种选定的与 PKU 相关的 PAH 蛋白错义变异体的细胞稳定性、定位和与野生型 PAH 的相互作用。一些变异体在人细胞中的水平降低,而在蛋白酶体抑制剂存在的情况下水平增加,表明这些蛋白质是蛋白酶体的靶标。我们发现,所有测试的 PAH 变异体都保留了与野生型 PAH 结合的能力,而且都没有形成聚集体,这表明它们的结构只是轻度不稳定。在所有情况下,PAH 变异体都被辅因子四氢生物蝶呤(BH 4 )稳定,这种分子已知可以缓解某些 PKU 患者的症状。使用 PAH 的全长结构对所有可能的单点错义变异体进行的生物物理计算显示,预测的蛋白质稳定性与在细胞中观察到的稳定性之间存在很强的相关性。这一观察结果解释了先前观察到的预测蛋白质失稳损失与疾病严重程度之间的相关性,我们也使用新的计算观察到了这种相关性。因此,我们提出许多与疾病相关的 PAH 变异体在结构上是不稳定的,这反过来又导致蛋白酶体降解和细胞内 PAH 蛋白的含量不足。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验